title: Hemopatch Application for Ventricular Wall Laceration in Redo Cardiac Surgical Procedures.
abstract: As survival among patients with complex congenital heart disease continues to improve, long-term survivors frequently require redo surgical procedures, with potentially escalating technical difficulty and bleeding risk. This report describes our experience with a new hemostatic pad, Hemopatch (Baxter Deutschland GmbH, Unterschleissheim, Germany) in redo cardiac surgery.
authors.affiliation: Department of Pediatric Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. Electronic address: stany.sandrio@uk-erlangen.de.
authors.forename: Stany
authors.initials: S
authors.lastname: Sandrio
authors.affiliation: Department of Pediatric Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: Ariawan
authors.initials: A
authors.lastname: Purbojo
authors.affiliation: Department of Pediatric Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Cesnjevar
authors.affiliation: Department of Pediatric Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: André
authors.initials: A
authors.lastname: Rüffer
mesh_terms: D000293:Adolescent; D006348:Cardiac Surgical Procedures; D005260:Female; D006335:Heart Injuries / Q000150:complications*; D006352:Heart Ventricles / Q000293:injuries*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology*; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D022125:Lacerations / Q000150:complications* / Q000209:etiology; D012086:Reoperation / Q000009:adverse effects
chemical_list: D006490:Hemostatics